JP2024528503A5 - - Google Patents
Info
- Publication number
- JP2024528503A5 JP2024528503A5 JP2023579696A JP2023579696A JP2024528503A5 JP 2024528503 A5 JP2024528503 A5 JP 2024528503A5 JP 2023579696 A JP2023579696 A JP 2023579696A JP 2023579696 A JP2023579696 A JP 2023579696A JP 2024528503 A5 JP2024528503 A5 JP 2024528503A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163216119P | 2021-06-29 | 2021-06-29 | |
| US63/216,119 | 2021-06-29 | ||
| US202263353953P | 2022-06-21 | 2022-06-21 | |
| US63/353,953 | 2022-06-21 | ||
| PCT/US2022/035561 WO2023278607A1 (en) | 2021-06-29 | 2022-06-29 | Leucine-rich repeat kinase 2 (lrrk2) irna agent compositions and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024528503A JP2024528503A (ja) | 2024-07-30 |
| JPWO2023278607A5 JPWO2023278607A5 (https=) | 2025-07-07 |
| JP2024528503A5 true JP2024528503A5 (https=) | 2025-07-07 |
Family
ID=84692073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023579696A Pending JP2024528503A (ja) | 2021-06-29 | 2022-06-29 | ロイシンリッチリピートキナーゼ２（ＬＲＲＫ２）ｉＲＮＡ剤組成物およびその使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240301426A1 (https=) |
| EP (1) | EP4363588A1 (https=) |
| JP (1) | JP2024528503A (https=) |
| KR (1) | KR20240033237A (https=) |
| AU (1) | AU2022303358A1 (https=) |
| BR (1) | BR112023027446A2 (https=) |
| CA (1) | CA3225740A1 (https=) |
| CL (3) | CL2023003984A1 (https=) |
| CO (1) | CO2023018579A2 (https=) |
| IL (1) | IL309548A (https=) |
| MX (1) | MX2024000065A (https=) |
| TW (1) | TW202317149A (https=) |
| WO (1) | WO2023278607A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024238385A2 (en) * | 2023-05-12 | 2024-11-21 | Alnylam Pharmaceuticals, Inc. | Single-stranded loop oligonucleotides |
| CN121712891A (zh) * | 2023-06-20 | 2026-03-20 | 阿达尔克斯制药有限公司 | Lrrk2调节组合物及其使用方法 |
| AU2024353921A1 (en) | 2023-09-27 | 2026-04-16 | Neuro3 Therapeutics (Suzhou) Ltd. | Novel sirna constructs, therapeutics, and modifications |
| CN120082552A (zh) * | 2023-12-01 | 2025-06-03 | 艾码生物科技(南京)有限公司 | 初级-miRNA及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014110205A1 (en) * | 2013-01-11 | 2014-07-17 | Children's Medical Center Corporation | Methods and compositions for the production of sirnas |
| TWI833770B (zh) * | 2018-06-27 | 2024-03-01 | 美商Ionis製藥公司 | 用於減少 lrrk2 表現之化合物及方法 |
-
2022
- 2022-06-29 JP JP2023579696A patent/JP2024528503A/ja active Pending
- 2022-06-29 TW TW111124391A patent/TW202317149A/zh unknown
- 2022-06-29 AU AU2022303358A patent/AU2022303358A1/en active Pending
- 2022-06-29 WO PCT/US2022/035561 patent/WO2023278607A1/en not_active Ceased
- 2022-06-29 IL IL309548A patent/IL309548A/en unknown
- 2022-06-29 CA CA3225740A patent/CA3225740A1/en active Pending
- 2022-06-29 MX MX2024000065A patent/MX2024000065A/es unknown
- 2022-06-29 US US18/575,157 patent/US20240301426A1/en active Pending
- 2022-06-29 BR BR112023027446A patent/BR112023027446A2/pt unknown
- 2022-06-29 EP EP22834164.0A patent/EP4363588A1/en active Pending
- 2022-06-29 KR KR1020247003234A patent/KR20240033237A/ko active Pending
-
2023
- 2023-12-28 CO CONC2023/0018579A patent/CO2023018579A2/es unknown
- 2023-12-29 CL CL2023003984A patent/CL2023003984A1/es unknown
-
2025
- 2025-01-20 CL CL2025000168A patent/CL2025000168A1/es unknown
- 2025-10-28 CL CL2025003326A patent/CL2025003326A1/es unknown